🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and intraocular pressur...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00761709
Treatments Being Tested
The objectives of this study are to evaluate the safety and analgesic effic...
Status
Completed
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT02081703
This is a phase I study evaluating safety and tolerability through the inci...
Status
Completed
Location
Investigacion e Innovacion en Medicina Traslacional
Start Date
2024-02-08
Trial ID
NCT06352541
A Multi-Center, Phase 2, Randomized, Double-Masked, Parallel-Group, Vehicle...
Status
Completed
Location
Andover Eye Associates
Start Date
2019-04-23
Trial ID
NCT03916042
This study will evaluate the safety and efficacy of AGN-210669 ophthalmic s...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01291108
Treatments Being Tested
To compare the safety and tolerability of brimonidine tartrate ophthalmic s...
Status
Completed
Location
Bausch Site 3
Start Date
2014-02-22
Trial ID
NCT01959243
The purpose of this study is to determine the intraocular Pressure (IOP) lo...
Status
Completed
Location
Clinical Site
Start Date
2012-09
Trial ID
NCT01687426
Treatments Being Tested
A study to evaluate the safety and efficacy of AGN-199201 alone, AGN-190584...
Status
Completed
Location
Multiple Locations
Start Date
2014-07
Trial ID
NCT02197806
Treatments Being Tested
The purpose of this trial is to determine the safety of IVMED-85 eye drops ...
Status
Recruiting
Location
Total Eye Care, P.A.
Start Date
2026-02-04
Trial ID
NCT07370584
Treatments Being Tested
A randomized, controlled, double-masked, investigator-initiated trial to ev...
Status
Completed
Location
Stephenson Eye Associates
Start Date
2022-10-11
Trial ID
NCT05514041
Treatments Being Tested